- Home
- FLNA vs PGZ Comparison
FLNA vs PGZ Comparison
Compare FLNA & PGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FLNA | PGZ |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.8M | 66.6M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | FLNA | PGZ |
|---|---|---|
| Price | $0.70 | $8.84 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.50 | N/A |
| AVG Volume (30 Days) | ★ 4.5M | 18.3K |
| Earning Date | 11-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.26% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $41,119,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.67 | $8.72 |
| 52 Week High | $2.03 | $10.58 |
Technical Indicators
Market Signals| Indicator | FLNA | PGZ |
|---|---|---|
| Relative Strength Index (RSI) | 38.92 | 34.72 |
| Support Level | $0.70 | N/A |
| Resistance Level | $1.03 | $10.28 |
| Average True Range (ATR) | 0.06 | 0.14 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 0.09 | 20.99 |
Price Performance
Historical ComparisonAbout FLNA Filana Therapeutics Inc. Common Stock
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
About PGZ Principal Real Estate Income Fund of Beneficial Interest
Principal Real Estate Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to provide high current income with capital appreciation by investing in commercial real estate-related securities. The company does its investments in USA, Australia, Japan, France, Great Britain, Canada, Hong Kong, Singapore, South Korea, British Virgin Islands and more.